Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior
NCT03046524 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-02-07
Summary
Objectives:
1. Identify the clinical characteristics of parathyroid (PTH) cancer and PTH atypical neoplasms
2. Investigate if PTH carcinoma and atypical neoplasm present a biological behaviour and have a different impact on the health of the patients
Conditions
- Parathyroid Carcinoma
- Parathyroid Neoplasm
Interventions
- OTHER
-
Chart Review
Data between the years of 1/1/2002 and 12/31/2013 analyzed.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Nancy D. Perrier, MD · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-06
- Primary Completion
- 2017-10-16
- Completion
- 2017-10-16
Countries
- United States
Study Locations
More Related Trials
-
High-risk Recurrent or Second Primary HNSCC With PD-1 Antibody Adjuvant After Salvage Surgery(RePASS)
NCT04126460 ·Status: UNKNOWN ·Phase: PHASE2
-
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
NCT01847326 ·Status: COMPLETED ·Phase: PHASE1
-
Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
NCT00003525 ·Status: TERMINATED ·Phase: PHASE2
-
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
NCT03010150 ·Status: RECRUITING
-
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
NCT03678649 ·Status: UNKNOWN ·Phase: PHASE2
-
Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137)
NCT02626000 ·Status: COMPLETED ·Phase: PHASE1
-
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
NCT00003489 ·Status: TERMINATED ·Phase: PHASE2
-
Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer
NCT03367884 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
NCT00798655 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy
NCT05283226 ·Status: RECRUITING ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence
NCT01142414 ·Status: WITHDRAWN ·Phase: PHASE3
-
Calcium Electroporation for Head and Neck Cancer
NCT03051269 ·Status: UNKNOWN ·Phase: PHASE1
-
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
NCT06575322 ·Status: RECRUITING
-
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
NCT02281955 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
NCT04974398 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT01154920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
NCT05172258 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
NCT04589624 ·Status: RECRUITING ·Phase: PHASE1
-
Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer
NCT00347256 ·Status: WITHDRAWN ·Phase: NA
-
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
NCT00002546 ·Status: COMPLETED ·Phase: PHASE3
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
NCT00004227 ·Status: TERMINATED ·Phase: PHASE3
-
Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
NCT01528137 ·Status: TERMINATED ·Phase: PHASE1
-
Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer
NCT01236547 ·Status: COMPLETED ·Phase: PHASE2
-
Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC
NCT00158652 ·Status: COMPLETED ·Phase: PHASE3